Key takeaways from the new framework agreement for medical devices in France

In July, the Economic Committee for Health Products (CEPS— the French price negotiation payer body), the National Union of the Medical Technology Industry (Snitem— the main French Medtech industry association), and other organizations representing medical device players signed a new framework agreement.  This comes 10 years after the previous agreement expired and after over three years of negotiations. Valid until July 2027, this agreement sets the key rules, principles, and considerations that govern how the CEPS determines the price deserved by medical devices and services for individual use at launch and over time.
 

Our experts take a closer look at some of the key takeaways for the Medtech industry from this new framework agreement.

1. Medtech companies are now involved in the conventional policy monitoring and can attempt to shape it.…